SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS

Clinical trials for SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS trials appear

Sign up with your email to follow new studies for SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New hope for teens with silent kidney damage

Disease control Not yet recruiting

This study is testing whether a medication called dapagliflozin can help protect the kidneys of teenagers who have early signs of kidney disease, specifically too much protein in their urine. The trial will involve 200 adolescents in Mexico, who will receive either the real drug …

Matched conditions: SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS

Phase: PHASE4 • Sponsor: Centenario Hospital Miguel Hidalgo • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS

Get alerted when new SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS trials appear

New hope for teens with silent kidney damage